Insider Shareholders with Direct Ownership of Tarsus Pharmaceuticals, Inc. (TARS)
This section provides a comprehensive overview of the insiders with direct ownership of Tarsus Pharmaceuticals, Inc. (TARS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Tarsus Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Vivo Capital Ix, Llc
> 10% Shareholder |
3,245,035 | 0 | 3,245,035 $172 Million | 1 |
Oct 20, 2020
Added 7.15%
|
|
Horowitz Limited Partnership Viii
> 10% Shareholder |
1,920,933 | 0 | 1,920,933 $102 Million | 1 |
Oct 20, 2020
Added 8.08%
|
|
Frazier Life Sciences Ix, L.P.
> 10% Shareholder |
1,917,157 | 0 | 1,917,157 $101 Million | 1 |
Oct 20, 2020
Added 14.02%
|
|
Michael Ackermann
Director |
71,699 | 29,165 | 1,208,273 $63.9 Million | 12 |
Jun 15, 2022
Added 0.35%
|
| 32,466 | 0 | 139,982 $7.41 Million | 3 |
Jun 24, 2024
Added 2.34%
|
|
|
Seshadri Neervannan
Chief Operating Officer |
18,342 | 7,117 | 64,767 $3.43 Million | 9 |
Mar 18, 2024
Reduced 7.01%
|
|
Aziz Mottiwala
Chief Commercial Officer |
29,859 | 31,470 | 54,075 $2.86 Million | 21 |
Mar 18, 2024
Reduced 8.1%
|
|
Bryan Wahl
General Counsel |
50,999 | 18,404 | 40,951 $2.17 Million | 15 |
Mar 18, 2024
Reduced 9.77%
|
|
Dianne C. Whitfield
Chief Human Resources Officer |
50,344 | 18,136 | 34,181 $1.81 Million | 15 |
Mar 18, 2024
Reduced 11.21%
|
|
Leonard M. Greenstein
Chief Financial Officer |
4,462 | 46,966 | 26,785 $1.42 Million | 15 |
Apr 20, 2023
Reduced 15.73%
|
|
Bobak R. Azamian
President/CEO and Board Chair |
41,323 | 14,867 | 26,456 $1.4 Million | 10 |
Mar 18, 2024
Reduced 28.25%
|
|
Jeffrey S Farrow
Officer |
27,881 | 10,445 | 18,136 $959,575 | 2 |
Jun 18, 2024
Reduced 36.55%
|
|
Wendy L Yarno
Director |
10,350 | 0 | 10,350 $547,618 | 3 |
Jun 24, 2024
Added 24.45%
|
|
Andrew D. Goldberg
Director |
6,350 | 0 | 6,350 $335,978 | 3 |
Jun 24, 2024
Added 34.54%
|
|
Rosemary A Crane
Director |
5,350 | 0 | 5,350 $283,068 | 2 |
Jun 24, 2024
Added 38.51%
|
|
Elizabeth Yeu Lin
Chief Medical Officer |
5,350 | 0 | 5,350 $283,068 | 2 |
Jun 24, 2024
Added 38.51%
|
|
Bhaskar Chaudhuri
Director |
5,350 | 0 | 5,350 $283,068 | 2 |
Jun 24, 2024
Added 38.51%
|
|
Mark J. Holdbrook
V.P., Clinical Affairs |
2,653 | 573 | 3,191 $168,835 | 4 |
Mar 20, 2023
Reduced 5.84%
|
|
Jose M. Trevejo
CHIEF MEDICAL OFFICER |
7,549 | 6,902 | 2,251 $119,100 | 9 |
Dec 20, 2023
Reduced 50.01%
|
|
Scott W Morrison
Director |
6,016 | 6,016 | 0 $0 | 4 |
Sep 30, 2024
Reduced 100.0%
|